Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Metallus
MTUS
$833M
| $35.7M | 0.02% |
1,603,352
-6,068
| -0.4% | -$127K |
|
452
Teradyne
TER
$50B
| $35.6M | 0.02% |
315,631
+87,150
| +38% | +$9.08M |
|
453
Globe Life
GL
$14B
| $35.5M | 0.02% |
304,974
-29,527
| -9% | -$3.61M |
|
|
HEES
454
DELISTED
H&E Equipment Services
HEES
| $35.3M | 0.02% |
549,525
-28,351
| -5% | -$1.55M |
|
455
Snowflake
SNOW
$98.1B
| $35M | 0.02% |
216,493
-1,986
| -0.9% | -$385K |
|
456
Landstar System
LSTR
$6.04B
| $34.9M | 0.02% |
180,955
+42,740
| +31% | +$8.12M |
|
457
PBF Energy
PBF
$7.49B
| $34.8M | 0.02% |
604,674
+547,509
| +958% | +$26.8M |
|
458
Meritage Homes
MTH
$4.78B
| $34.6M | 0.02% |
394,752
-30,816
| -7% | -$2.49M |
|
459
Ferrari
RACE
$67.8B
| $34M | 0.02% |
77,864
+7,336
| +10% | +$2.84M |
|
|
DAWN
460
DELISTED
Day One Biopharmaceuticals
DAWN
| $33.6M | 0.02% |
2,032,384
+336,281
| +20% | +$5.03M |
|
461
Edgewise Therapeutics
EWTX
$4.28B
| $32.9M | 0.02% |
1,805,312
+590,299
| +49% | +$9.38M |
|
462
Travelers Companies
TRV
$81.1B
| $32.8M | 0.02% |
142,630
-26,259
| -16% | -$5.61M |
|
|
VRNA
463
DELISTED
Verona Pharma
VRNA
| $32.7M | 0.02% |
2,031,994
+228,633
| +13% | +$3.95M |
|
|
UCTT
464
Ultra Clean Holdings
UCTT
$3.12B
| $32.6M | 0.02% |
709,549
-309,481
| -30% | -$12.6M |
|
465
MakeMyTrip
MMYT
$5.38B
| $32.6M | 0.02% |
458,534
+269,988
| +143% | +$15.4M |
|
466
Disc Medicine
IRON
$2.81B
| $32.5M | 0.02% |
521,773
+78,595
| +18% | +$5.1M |
|
467
Prothena Corp
PRTA
$448M
| $32.4M | 0.02% |
1,309,590
-726,394
| -36% | -$21.6M |
|
468
Baker Hughes
BKR
$58.3B
| $32.4M | 0.02% |
968,208
+14,610
| +2% | +$451K |
|
469
Popular Inc
BPOP
$11B
| $32.1M | 0.02% |
364,735
-5
| -0% | -$419 |
|
470
The Bancorp
TBBK
$2.81B
| $32.1M | 0.02% |
958,996
-14,138
| -1% | -$563K |
|
|
AVDX
471
DELISTED
AvidXchange
AVDX
| $32M | 0.02% |
2,435,793
-27,840
| -1% | -$334K |
|
472
Cable One
CABO
$237M
| $32M | 0.02% |
75,537
+11,950
| +19% | +$5.88M |
|
473
Kemper
KMPR
$1.81B
| $31.9M | 0.02% |
515,487
+57,979
| +13% | +$3.33M |
|
474
AAR Corp
AIR
$5.4B
| $31.8M | 0.02% |
530,682
+64,274
| +14% | +$4M |
|
|
RNAM
475
DELISTED
Avidity Biosciences
RNAM
| $31.7M | 0.02% |
1,242,833
+1,216,730
| +4,661% | +$19.1M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.